1-4 of 4
Keywords: MicroRNA-145
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles

Retraction: Elevated microRNA-145 inhibits the development of oral squamous cell carcinoma through inactivating ERK/MAPK signaling pathway by down-regulating HOXA1

Open Access
Journal: Bioscience Reports
Biosci Rep (2022) 42 (11): BSR-2018-2214_RET.
https://doi.org/10.1042/BSR-2018-2214_RET
Published: 10 November 2022
... License 4.0 (CC BY) . Extracellular-signal-regulated kinase/mitogen activated protein kinase Homeobox A1 MicroRNA-145 Oral squamous cell carcinoma ...
View articletitled, Retraction: Elevated microRNA-145 inhibits the development of oral squamous cell carcinoma through inactivating ERK/MAPK signaling pathway by down-regulating HOXA1
Open the PDF for Retraction: Elevated microRNA-145 inhibits the development of oral squamous cell carcinoma through inactivating ERK/MAPK signaling pathway by down-regulating HOXA1 in another window
Articles

Expression of Concern: Elevated microRNA-145 inhibits the development of oral squamous cell carcinoma through inactivating ERK/MAPK signaling pathway by down-regulating HOXA1

Open Access
Journal: Bioscience Reports
Biosci Rep (2022) 42 (9): BSR-2018-2214_EOC.
https://doi.org/10.1042/BSR-2018-2214_EOC
Published: 26 September 2022
... Homeobox A1 MicroRNA-145 Oral squamous cell carcinoma The Editorial Office has been made aware of potential issues surrounding the scientific validity of this paper hence has issued an Expression of Concern to notify readers whilst the Editorial Office investigates. A duplicated, modified region has...
View articletitled, Expression of Concern: Elevated microRNA-145 inhibits the development of oral squamous cell carcinoma through inactivating ERK/MAPK signaling pathway by down-regulating HOXA1
Open the PDF for Expression of Concern: Elevated microRNA-145 inhibits the development of oral squamous cell carcinoma through inactivating ERK/MAPK signaling pathway by down-regulating HOXA1 in another window
Articles

Elevated microRNA-145 inhibits the development of oral squamous cell carcinoma through inactivating ERK/MAPK signaling pathway by down-regulating HOXA1

Open Access
Junhai Ding, Dubin Sun, Pengfeng Xie
Journal: Bioscience Reports
Biosci Rep (2019) 39 (6): BSR20182214.
https://doi.org/10.1042/BSR20182214
Published: 25 June 2019
.... In the present study, we aim to explore the underlying mechanism by which microRNA-145 (miR-145) affected OSCC. Methods: Forty-eight patients diagnosed with OSCC were enrolled to obtain the OSCC tissues and adjacent normal tissues. The targeting relationship between miR-145 and Homeobox A1 (HOXA1) was verified...
View articletitled, Elevated microRNA-145 inhibits the development of oral squamous cell carcinoma through inactivating ERK/MAPK signaling pathway by down-regulating HOXA1
Open the PDF for Elevated microRNA-145 inhibits the development of oral squamous cell carcinoma through inactivating ERK/MAPK signaling pathway by down-regulating HOXA1 in another window
Articles

Long non-coding RNA MEG3 serves as a ceRNA for microRNA-145 to induce apoptosis of AC16 cardiomyocytes under high glucose condition

Open Access
Yiwei Chen, Zhifang Zhang, Diqi Zhu, Wenchuo Zhao, Fen Li
Journal: Bioscience Reports
Biosci Rep (2019) 39 (6): BSR20190444.
https://doi.org/10.1042/BSR20190444
Published: 07 June 2019
... and distributed under the Creative Commons Attribution License 4.0 (CC BY) . diabetic cardiomyopathy long non-coding RNA MEG3 microRNA-145 PDCD4 Long non-coding RNAs (lncRNAs) are a group of transcribed RNA molecules with more than 200 nucleotides in length and little or no protein-coding...
View articletitled, Long non-coding RNA MEG3 serves as a ceRNA for microRNA-145 to induce apoptosis of AC16 cardiomyocytes under high glucose condition
Open the PDF for Long non-coding RNA MEG3 serves as a ceRNA for microRNA-145 to induce apoptosis of AC16 cardiomyocytes under high glucose condition in another window